JBS Q1 2026 Earnings EPS Miss Pressures Shares as Cost Headwinds Persist GLMD Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage OBIO Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline in PreRevenue Phase NCMI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Advertising Environment UUUU Q1 2026 Earnings NarrowerThanExpected Loss as Uranium Market Remains Subdued